The global optical preclinical imaging market revenue was US$ 544.4 million in 2021. The global optical preclinical imaging market revenue is forecast to reach US$ 859.70 million by 2030, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2022 to 2030.
The process of visualizing living animals for research purposes, such as drug discovery and development, is called optical preclinical imaging. Researchers frequently use imaging modalities to monitor physiological or environmental changes in animals, whether at the organ, tissue, cell, or molecular levels. With the advent of non-invasive and in vivo imaging approaches, animal models have become increasingly valuable for research. The use of optical imaging in preclinical drug discovery and development is becoming increasingly popular. This modality provides an inside view of animals and allows for real-time monitoring of molecular processes at the molecular level. Easy to use, radiation-free, affordably priced, and has excellent sensitivity, this method is simple to use and has no side effects. In addition to monitoring disease progression, it can assess the effects of drug candidates with extremely high sensitivity.
Factors Influencing Market Growth
Increased demand for non-invasive imaging techniques and government funding will likely drive the global optical preclinical imaging market.
Factors such as a high product price that decreases adoption rates in academic institutions and a limited number of applications of each modality may negatively impact the growth of the global optical preclinical imaging market.
There are potential growth opportunities in the global optical preclinical imaging market due to improved healthcare infrastructure, increased unmet healthcare needs, and increased research and development. Additionally, the availability of such minimally invasive procedures makes the optical preclinical imaging market an attractive investment opportunity for key players in the global market.
Impact Analysis of COVID-19
COVID-19 pandemic led to a huge number of clinics and hospitals worldwide reorganizing to accommodate more cases of patients who had COVID-19. The rapidly rising number of COVID-19 cases caused a potential backlog in non-essential procedures. On the other hand, various preclinical research studies and activities, such as clinical trials for safety and efficacy, for the treatment of COVID-19 by researchers, companies, and governments, have spurred the growth of the optical preclinical imaging market.
Regional Insights
North America held the majority of the global optical preclinical imaging market share in 2021 and is forecast to continue dominating during the forecast period. It is due to the well-established pharmaceutical and biopharmaceutical research industries. The region is also a potential market for various products used in research activities due to the presence of a number of the world's leading pharmaceutical companies and biopharmaceutical companies.
During the forecast period, Asia-Pacific is forecast to witness notable growth. Due to an increase in research & development, an increase in facilities that offer optical preclinical imaging services, and increased investments in healthcare.
Leading Competitors
The leading prominent companies profiled in the global optical preclinical imaging market are:
Berthold Technologies GmbH & Co.KG
Endress+Hauser (Analytik Jena US LLC)
Fujifilm Corporation (Fujifilm VisualSonics Incorporated)
LI-COR Biosciences, Incorporated
Miltenyi Biotec
PerkinElmer, Incorporated
Rigaku Corporation (MILabs B.V.)
TriFoil Imaging
Vieworks Co., Limited
Vilber Smart Imaging Limited
Other Prominent Players
Scope of the Report
The global optical preclinical imaging market segmentation focuses on Modality, End-User, and Region.
Segmentation based on Modality
Bioluminescence & Fluorescence Imaging Systems
Standalone Fluorescence Imaging Systems
Optical + X-ray & Optical + CT
Segmentation based on End-User
Pharma & Biotech Companies
Academic & Government Research Institutes
Contract Research Organizations
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America
RELATED REPORT
Global Dermal Fillers Market By Material (Hyaluronic Acid,...
Global Veterinary Imaging Market By Product (Instrument, Software,...
Global Surgical Retractor Market By Product (Handheld, Self-retaining,...
Global Healthcare Interoperability Solutions Market By Level (Foundational,...
Global Connected Drug Delivery Devices Market By Product...
Global Stoma/Ostomy Care Market By Product Type (Ostomy...
Global Home Healthcare Market By Type (Devices, Software,...
Global Dry Mouth Relief Market By Type (OTC,...
Global Automated Hospitals Beds Market By Type (Semi-Automatic...
Global Urothelial Carcinoma Treatment Market By Type (Non-Invasive...
Global Bio Decontamination Market By Product (Equipment, Service,...
Global Cancer Gene Therapy Market Development Strategy Pre...
Global Wrist Fixator Procedure Kit Market Development Strategy...
Global Serum Market Development Strategy Pre and Post...
Global Video Colposcopes Market Development Strategy Pre and...
